Employers Could Be Hot Target For OTC Smoking-Cessation Sales – Survey
This article was originally published in The Tan Sheet
Executive Summary
Drug companies offering smoking-cessation products could stoke their sales by marketing to U.S. businesses, results of a Pfizer-sponsored survey show
You may also be interested in...
New Products In Brief
Bioriginal's flavored fish oils: The Canadian essential fatty acids provider launches flavored fish oil softgels combining a fruity taste and aroma as an alternative to standard capsules and to help dietary supplement manufacturers develop diverse product lines with enhanced consumer appeal. The offerings, available in custom and standard sizes, include molecularly distilled cod liver oil, a 3-6-9 combination and concentrated EPA and DHA fish oils. The firm says it developed them to overcome manufacturers' common challenges, including unpleasant flavor or odor and the fishy reflux that can be deterrents for consumers. Saskatoon, Saskatchewan-based Bioriginal cites studies not only linking the omega-3s found in fish oils to enhancing heart, brain, joint and eye health, but also showing 33% of Americans who believe they are deficient in omega-3s do not purchase fish oils...
WellPoint Consumer-Driven Plans Focus On Prevention, Healthy Behaviors
WellPoint's nationwide consumer-driven health plans (CDHP) will focus on preventive services such as smoking cessation, weight management programs and improving poor nutrition, the firm announced Aug. 22
Perrigo Builds Sales On Smoking Cessation, Eyes Prilosec OTC In 2007
Pursuit of private-label omeprazole for a possible 2007 launch fits Perrigo's ongoing strategy of focusing on new products to drive sales growth